-
Loading metrics
A Multicenter, Randomized Clinical Trial Comparing the Three-Weekly Docetaxel Regimen plus Prednisone versus Mitoxantone plus Prednisone for Chinese Patients with Metastatic Castration Refractory Prostate Cancer
- Tie Zhou,
- Shu-xiong Zeng,
- Ding-wei Ye,
- Qiang Wei,
- Xu Zhang,
- Yi-ran Huang,
- Zhang-qun Ye,
- Yong Yang,
- Wei Zhang,
- Ye Tian
x
- Published: January 27, 2015
- https://doi.org/10.1371/journal.pone.0117002